September 8, 2024
Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe with Julius Clinical

WAKE FOREST, N.C. |  ADELAIDE, AUS, May 31, 2024 – (ACN Newswire) – Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS, cardiometabolic, and rare diseases specialist CRO with extensive site relationships in the region.Meet the Avance Clinical team at BIO 2024 – Book a meeting now.Julius Clinical…
Read More

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *